The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth

Journal of Health Communication

Volumn 14, Issue 3, 2009, Pages 246-261

  Martinez, Lourdes S ^a   Lewis, Nehama ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ADVERTIZING; ANXIETY DISORDER; ARTICLE; ATTITUDE; CONSUMER; DEPRESSION; DRUG USE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PUBLIC OPINION; YOUNG ADULT;

EID: 67651087138     PISSN: 10810730     EISSN: 10870415     Source Type: Journal    
DOI: 10.1080/10810730902805820     Document Type: Article

References (43)

1. Basara, L. R. (1992). Direct-to-consumer advertising: Today's issues and tomorrow's outlook. Journal of Drug Issues, 22(2), 317-331.
2. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651-657.
3. Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (1999). Advertising-induced prescription drug requests: Patients' anticipated reactions to a physician who refuses. Journal of Family Practice, 48(6), 446-452.
4. Beltramini, R. F. (2006). Consumer believability of information in direct-to-consumer (DTC) advertising of prescription drugs. Journal of Business Ethics, 63, 333-343.
5. Brehm, S., & Brehm, J. W. (1981). Psychological reactance: A theory of freedom and control. New York: Academic Press.
6. Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of American Medical Association, 297(15), 1683-1696.
7. Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Williams, M. V., & Parker, R. M. (2004). Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9, 491-497.
8. Cheung, A. H., Emslie, G. J., & Mayes, T. L. (2006). The use of antidepressants to treat depression in children and adolescents. Canadian Medical Association Journal, 174(2), 193-200.
9. Clee, M. A., & Wicklund, R. A. (1980). Consumer behavior and psychological reactance. Journal of Consumer Research, 6(4), 389-405.
10. Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple regression/ correlation analysis for the behavioral sciences (3rd ed.). Hillsdale, NJ: Erlbaum.
11. Deshpande, A., Menon, A., Perri III, M., & Zinkhan, G. (2004). Direct-to-consumer advertising and its utility in health care decision making: A consumer perspective. Journal of Health Communication, 9, 499-513.
12. Donohue, J. M., & Berndt, E. R. (2004). Effects of direct-to-consumer advertising on medication choice: The case of antidepressants. Journal of Public Policy and Marketing, 23(2), 115-127.
13. Donohue, J. M., Cevasco, M., & Rosenthal, M. B. (2007). A decade of direct-to-consumer advertising. New England Journal of Medicine, 357(7), 673-681.
14. Food and Drug Administration (FDA). (1985). Direct-to-consumer advertising of prescription drugs: Withdrawal of moratorium. Federal Register, 50, 36677-36678.
15. Friedman, M., & Gould, J. (2007). Physicians' attitudes toward direct-to-consumer prescription drug marketing. Journal of Medical Marketing, 7, 33-44.
16. Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F., & Barg, F. K. (2007). Creating demand for prescription drugs: A content analysis of television direct-to-consumer advertising. Annals of Family Medicine, 5, 6-13.
17. Gellad, Z. F., & Lyles, K. W. (2007). Direct-to-consumer advertising of pharmaceuticals. American Journal of Medicine, 120, 475-480.
18. Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2006). Relationship between anti-depressant prescription rates and rate of early adolescent suicide. American Journal of Psychiatry, 163, 1898-1904.
19. Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
20. Herzenstein, M., Misra, S., & Posavac, S. S. (2004). How consumers' attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Marketing Letters, 14(4), 201-212.
21. Holmer, A. F. (1999). Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Journal of the American Medical Association, 281(4), 380-382.
22. Isacsson, G. (2000). Suicide prevention - A medical breakthrough? Acta Psychiatrica Scandinavica, 102, 113-117.
23. Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., & Franks, P. (2005). Influence of patients requests for direct-to-consumer advertised antidepressants. Journal of the American Medical Association, 293(16), 1995-2002.
24. Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. Public Library of Science, 2(12), e392.
25. Markowitz, S., & Cuellar, A. (2007). Antidepressants and youth: Healing or harmful? Social Science and Medicine, 64, 2138-2151.
26. Mintzes, B., Barer, M. L., Kravitz, R. L., Kazanjian, A., Bassett, K., Lexchin, J., Evans, R. G., Pan, R., & Marion, S. A. (2002). Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: Two site cross-sectional survey. British Medical Journal, 324(7332), 278-279.
27. Monaghan, M. S., Galt, K. A., Turner, P. D., Houghton, B. L., Rich, E. C., & Bergman-Evans, B. (2003). Student understanding of the relationship between the health professions and the pharmaceutical industry. Teaching and Learning in Medicine, 15(1), 14-20.
28. Morris, A. W., Gadson, S. L., & Burroughs, V. (2007). "For the good of the patient," survey of the physicians of the national medical association regarding perceptions of DTC advertising, part II, 2006. Journal of the National Medical Association, 99(3), 287-293.
29. Morris, L. A., & Pines, W. L. (2000). Regulation of pharmaceutical promotion in the twenty-first century. Drug Information Journal, 34, 861-873.
30. Murray, E., Lo, B., Pollack, L., Donelan, K., & Lee, K. (2004). Direct-to-consumer advertising: Public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. Journal of the American Board of Family Practice, 17, 6-18.
31. Narayanan, S., Desiraju, R., & Chintagunta, P. K. (2004). Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. Journal of Marketing, 68(4), 90-105.
32. Olfson, M., Marcus, S. C., & Shaffer, D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults: A case control study. Archives of General Psychiatry, 63, 865-872.
33. Olfson, M., Shaffer, D., Marcus, S. C., & Greenberg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry, 60, 978-982.
34. Pines, W. L. (1997). New challenges for medical product promotion and its regulation. Food and Drug Law Journal, 52, 61-65.
35. Pines, W. L. (1999). A history and perspective on direct-to-consumer promotion. Food and Drug Law Journal, 54, 489-518.
36. Robinson, A. R., Hohmann, K. B., Rifkin, J. I., Topp, D., Gilroy, C. M., Pickard, J. A., & Anderson, R. J. (2004). Direct-to-consumer pharmaceutical advertising: Physician and public opinion and potential effects on the physician-patient relationship. Archives of Internal Medicine, 164, 427-432.
37. Safer, D. J., & Zito, J. M. (2007). Do antidepressants reduce suicide rates? Public Health, 121, 274-277.
38. Shaffer, D., & Craft, L. (1999). Methods of adolescent suicide prevention. Journal of Clinical Psychiatry, 60(2 Suppl.), 70-74.
39. Singh, T., & Smith, D. (2005). Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing, 22(7), 369-378.
40. Sorofman, B. (1992). Drug promotion in self-care and self-medication. Journal of Drug Issues, 22(2), 377-389.
41. U.S. Department of Health and Human Services. (1999). Mental Health: A Report of the Surgeon General. Rockville, MD: Author.
42. Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 19(2), 110-128.
43. Woloshin, S., Schwartz, L. M., Tremmel, J., & Welch, H. G. (2001). Direct-to-consumer advertisements for prescription drugs: What are Americans being sold? The Lancelot, 358, 1141-1146.